Parvin Asset Management’s AbbVie ABBV Stock Holding History

Parvin Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$912K	Hold	3,625	–	–	0.72%	50
2026 Q1	$788K	Hold	3,625	–	–	0.57%	58
2025 Q4	$828K	Sell	3,625 -1,237	-25%	-$282K	0.66%	54
2025 Q3	$1.13M	Buy	4,862 +112	+2%	+$22.8K	0.98%	29
2025 Q2	$882K	Sell	4,750 -65	-1%	-$12.1K	0.89%	36
2025 Q1	$1.01M	Sell	4,815 -1,360	-22%	-$264K	1.11%	21
2024 Q4	$1.1M	Buy	+6,175	New	+$1.14M	1.16%	20

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Parvin Asset Management's ABBV Position: Q2 2026 in Review

Parvin Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 3,625 shares worth $912K. The position accounts for 0.72% of the portfolio, ranked #50.

Parvin Asset Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.13M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Parvin Asset Management held 3,625 shares of AbbVie worth $912K as of Q2 2026.
Parvin Asset Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.72% of Parvin Asset Management's portfolio in Q2 2026, its #50 holding.
Parvin Asset Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Parvin Asset Management's AbbVie position peaked at $1.13M in Q3 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.